Meenaxy Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.98 Cr
as on 16-11-2024
- Company Age 29 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 23.10 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.96 Cr
as on 16-11-2024
- Revenue -21.61%
(FY 2023)
- Profit 12.71%
(FY 2023)
- Ebitda
- Net Worth 14.73%
(FY 2023)
- Total Assets 6.14%
(FY 2023)
About Meenaxy Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.98 Cr.
The company currently has active open charges totaling ₹23.10 Cr. The company has closed loans amounting to ₹4.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Padmanabhuni Sanjay, Padmanabhuni Amar, Raja Kodali, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG1995PTC022370
- Company No.
022370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Meenaxy Pharma Private Limited offer?
Meenaxy Pharma Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Pharma Ingredients & Raw Materials, Pharmaceutical Pellets, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, API (Active Pharmaceutical Ingredients), Flavours & Aromatics, Food Stabilizer, Common Disease Medicines.
Who are the key members and board of directors at Meenaxy Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anusha Kodali  | Managing Director | 22-Apr-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmanabhuni Amar | Whole-Time Director | 22-Apr-2023 | Current |
| Padmanabhuni Sanjay | Director | 24-Nov-1995 | Current |
| Raja Kodali | Director | 22-Apr-2023 | Current |
Financial Performance and Corporate Structure Insights of Meenaxy Pharma.
Meenaxy Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.61% decrease. The company also saw a substantial improvement in profitability, with a 12.71% increase in profit. The company's net worth Soared by an impressive increase of 14.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Meenaxy Pharma?
In 2023, Meenaxy Pharma had a promoter holding of 94.50% and a public holding of 5.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai Med Pharma Systems Private LimitedActive 29 years 11 monthsPadmanabhuni Sanjay is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Jul 2022 | ₹1.50 Cr | Open |
Others Creation Date: 28 Jun 2022 | ₹3.08 Cr | Open |
Others Creation Date: 29 Sep 2020 | ₹9.08 M | Open |
How Many Employees Work at Meenaxy Pharma?
Meenaxy Pharma has a workforce of 80 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meenaxy Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meenaxy Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
